Abstract: The present invention relates to a genetically modified plant having an increased amount of oil in its green biomass as compared to the oil in the green biomass of its non-genetically modified counterpart. The plants may be used for producing bio-fuels such as biodiesel fuel.
Type:
Grant
Filed:
August 5, 2014
Date of Patent:
February 21, 2017
Assignees:
Biotechnology Foundation, Inc., Thomas Jefferson University
Abstract: The present invention relates to a genetically modified plant having an increased amount of oil in its green biomass as compared to the oil in the green biomass of its non-genetically modified counterpart. The plants may be used for producing bio-fuels such as biodiesel fuel.
Type:
Grant
Filed:
June 12, 2008
Date of Patent:
September 30, 2014
Assignees:
Biotechnology Foundation, Inc., Thomas Jefferson University
Abstract: The invention as described herein provides compositions and methods for cancer immunotherapy and cancer detection. In particular, the invention discloses plant-derived human monoclonal antibodies that bind human carcinoma antigens in cancer cell lines.
Type:
Application
Filed:
April 23, 2008
Publication date:
February 12, 2009
Applicants:
Biotechnology Foundation, Inc., The Chancellor, Masters and Scholars of the University of Oxford, University of Oxford
Abstract: Human rabies monoclonal antibodies (rabies MAbP) comprising rabies human MAb S057 heavy chain and light chain subunits are expressed and assembled in plants under the control of two strong constitutive promoters. Additionally, regulatory control elements such as alfalfa mosaic virus untranslated leader sequence and Lys-Asp-Glu-Leu (KDEL) endoplasmic reticulum retention signal were linked at the N- and C-terminus of the heavy chain of human rabies MAbP, respectively to regulate expression of the rabies MAbP. Rabies MAbP was as effective at neutralizing the activity of the rabies virus as the mammalian-derived antibody (MAbM) or human rabies immunoglobulin (HRIG).
Type:
Application
Filed:
June 2, 2004
Publication date:
June 22, 2006
Applicants:
BIOTECHNOLOGY FOUNDATION, INC., UNIVERSITY OF OXFPRD
Abstract: The invention as described herein provides compositions and methods for cancer immunotherapy and cancer detection. In particular, the invention discloses plant-derived human monoclonal antibodies that bind human carcinoma antigens in cancer cell lines.
Type:
Application
Filed:
June 2, 2004
Publication date:
June 23, 2005
Applicants:
Biotechnology Foundation, Inc., The Chancellor, Masters and Scholars of the University of Oxford, University of Oxford